Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Globenewswire· 2025-09-16 05:29
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate test. Acquisition of ExoDx Business On August 5, 2025, mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. fr ...
ERES Provides Update on Previously Disclosed Strategic Dispositions, Declares Special Distribution and Cessation of Monthly Distribution
Globenewswire· 2025-09-16 05:20
TORONTO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- European Residential Real Estate Investment Trust (“ERES” or “the REIT”) (TSX:ERE.UN) announced today that, subject to the completion of standard notary procedures, it has closed on the previously announced disposition of entities owning 1,446 residential suites in the Netherlands for aggregate proceeds, net of an adjustment for deferred taxes and other adjustments, of approximately €336 million. ERES further announced that, in addition to having closed on the sal ...
Kimco Realty® Achieves ‘A-’ Credit Rating from S&P Global
Globenewswire· 2025-09-16 05:15
JERICHO, N.Y., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, today announced the company achieved an ‘A-’ credit rating with a stable outlook from S&P Global Ratings (“S&P”), making it one of just 13 publicly-listed U.S. REITs with a credit rating of ‘A-’ or better from either S&P or Fitch Ratings. In its note, S&P ci ...
Legence Announces Closing of Initial Public Offering and Partial Exercise of Overallotment Option
Globenewswire· 2025-09-16 05:07
SAN JOSE, Calif., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Legence Corp. (“Legence”) announced today the closing of its initial public offering (the “offering”) of 26,000,000 shares of its Class A common stock (the “Common Stock”) at a price to the public of $28.00 per share. In addition, the underwriters partially exercised their option and purchased 3,487,627 additional shares of Common Stock. The Common Stock began trading on the Nasdaq Global Select Market (“Nasdaq”) on September 12, 2025 under the ticker sym ...
CEMATRIX Announces $11.9 Million in New Contract Awards
Globenewswire· 2025-09-16 05:00
CALGARY, Alberta, Sept. 15, 2025 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) ("CEMATRIX" or the "Company"), a specialty construction contractor that produces cellular concrete solutions on site and is a leading manufacturer and supplier of cellular concrete in North America announced today that it has won $11.9 million in new contract awards. New Contract Award Details: The awards are in the form of contracts and contracts in process. Some of the projects are currently scheduled to ...
RISE Dispensaries to Launch Adult-Use Cannabis Sales at RISE Minnesota Locations on September 17
Globenewswire· 2025-09-16 05:00
Adult-Use Cannabis Sales to Begin at 9:00 a.m. on September 17 at RISE Dispensaries in Brooklyn Park, Eagan, Mankato, New Hope, and WillmarCHICAGO and VANCOUVER, British Columbia, Sept. 15, 2025 (GLOBE NEWSWIRE) -- RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced it will commence adult-use cannabis sales at Minnesota retail locations in Brooklyn Park, Eagan, Mankato, New Hope, and Will ...
TopBuild Announces Pricing of its Senior Notes Offering
Globenewswire· 2025-09-16 04:59
DAYTONA BEACH, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD) (“TopBuild” or the “Company”), a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, today announced the pricing of its previously announced private offering of $750.0 million aggregate principal amount of senior notes due 2034 (the “notes”) to be 5.625%. TopBuild intends to use the ...
National Bank Holdings Corporation announces merger agreement with Vista Bancshares, Inc.
Globenewswire· 2025-09-16 04:50
Pro Forma NBHC $12.4 billion in total assets and $10.4 billion in total depositsExpansion in fast-growing and attractive Dallas-Fort Worth metroplexTransaction expected to be 17%(1) accretive to NBHC’s earnings with tangible book value earn-back in approximately 3 yearsDeal approved by both Boards of Directors, expected to close in Q1 2026 DENVER and DALLAS, Sept. 15, 2025 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC, “NBHC” or the “Company”), the holding company for NBH Bank, today an ...
TurnOnGreen Begins Supply of Qualified Power Systems to Major Defense Contractor
Globenewswire· 2025-09-16 04:30
MILPITAS, Calif., Sept. 15, 2025 (GLOBE NEWSWIRE) -- TurnOnGreen, Inc. (OTC: TOGI) (“TurnOnGreen” or the “Company”) and its defense production division Digital Power Corporation (“DPC”) today announced shipment of the first production lot of proprietary power conversion systems to a major defense OEM for integration into Light Armored Vehicle (LAV) and Rugged Tactical Reconnaissance Vehicle (RTRV) platforms. This milestone marks the transition from engineering development to full production on a multi‑year ...
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Globenewswire· 2025-09-16 04:30
融资交易概述 - 公司完成注册直接发行 以每股1.70美元价格发行2,764,710股普通股 同时通过私募发行可认购5,529,420股的未注册认股权证 行权价为每股1.50美元 [1] - 本次发行总收益约470万美元 若认股权证全部现金行权 可额外获得约830万美元潜在总收益 [1][3] 交易结构细节 - 普通股发行依据S-3表格货架注册声明(文件号333-271883) 该注册于2023年5月26日获SEC宣布生效 [4] - 未注册认股权证依据证券法第4(a)(2)条和/或D条例发行 其及对应普通股未在证券法或州证券法下注册 [5] 资金用途与参与机构 - 发行净收益将用于营运资金和一般公司用途 [3] - H.C. Wainwright & Co担任本次发行的独家配售代理 [2] 公司背景 - 公司为临床阶段生物技术公司 专注于开发针对流感、病毒性胃肠炎、COVID和肝炎的创新抗病毒治疗 [7] - 采用基于结构的独特技术和诺贝尔奖获奖专业知识 开发首创和最佳抗病毒药物 [7]